Top Analyst Upgrades and Downgrades: ABB, BofA, J.P. Morgan, SanDisk, Micron, Mylan and More

Callon Petroleum Co. (NYSE: CPE) was reiterated Buy and the price target was raised to $17 from $15 (versus a $10.39 close) at Canaccord Genuity after an accretive acquisition analysis.

Concur Technologies Inc. (NASDAQ: CNQR) saw its shares soar 10% on reports and rumors that it is shopping itself. Baird says to take the profit now by downgrading the stock to Neutral from Outperform.

Fifth Third Bancorp (NASDAQ: FITB) was reiterated as Buy and called undervalued with a $25 price target (versus a $20.51 close) at Sterne Agee.

JPMorgan Chase & Co. (NYSE: JPM) was raised to Buy from Neutral at Nomura.

Micron Technology Inc. (NASDAQ: MU) was maintained as Buy with a $40 price target (versus a $31.51 close) by Sterne Agee after looking at Samsung as a proxy.

READ ALSO: J.P. Morgan’s 4 Top Telecom and Tower Stocks to Buy Now

Mylan Inc. (NASDAQ: MYL) was reiterated as Buy at Argus, but the firm lowered its 2014 earnings estimates slightly.

Quest Diagnostics Inc. (NYSE: DGX) was maintained as Buy but was added to the prized Conviction Buy List at Goldman Sachs.

Rangold Resources Ltd. (NASDAQ: GOLD) was downgraded to Hold from Buy at Deutsche Bank.

SanDisk Corp. (NASDAQ: SNDK) was maintained as Buy with a $125 price target (versus $95.64 close) by Sterne Agee after looking at Samsung as a proxy.

Stericycle, Inc. (NASDAQ: SRCL) was downgraded to Neutral from Buy at Goldman Sachs.

Scorpio Bulkers Inc. (NYSE: SALT) was started with a Buy and given a $13 price target (versus $7.96 close) at Jefferies.

Star Bulk Carriers Corp. (NASDAQ: SBLK) initiated with a Buy at Jefferies

In case you missed Tuesday’s analyst upgrades and downgrades, they included shares of Tesla, Sandridge, American Water Works, Exelixis, Endo Pharma, The Gap, Groupon, Staples and more.

READ ALSO: 4 Chip Stocks to Buy That Don’t Need PC Growth for a Strong Finish to 2014